Patent directory · USPTO A61K / A61P
Patents matching “combination”
418 pharma patents match "combination" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 418 pharmaceutical patents matching "combination" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11510929
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
granted -
US 11497781
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
granted -
US 11497713
Combination taxoid nanoemulsion with immunotherapy in cancer
granted -
US 11491215
Antigenic combinations against Francisella bacteria and related nanolipoprotein particles, compositions, methods and systems
granted -
US 11491145
Combination therapies comprising targeted therapeutics
granted -
US 11478428
Combinations of beta-lactam compounds and probenecid and uses thereof
granted -
US 11464774
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
granted -
US 11464856
Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers
granted -
US 11464768
Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
granted -
US 11458127
Methods of treating brain tumors using combination therapy
granted -
US 11452723
Combination dosage form of a mu opioid receptor antagonist and an opioid agent
granted -
US 11440963
Combination PDL1 and TGF-beta blockade in patients with HPV+ malignancies
granted -
US 11426379
Combination of local and systemic therapies for enhanced treatment of dermatologic conditions
granted -
US 11421034
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer
granted -
US 11414489
Combination therapy with a hyaluronan-degrading enzyme and an immune checkpoint inhibitor
granted -
US 11400123
Combination product for prophylaxis and treatment of irritable bowel syndrome
granted -
US 11397184
Selection of patients for combination therapy
granted -
US 11382897
Therapeutic combination for treatment of cerebellar ataxia
granted -
US 11365265
Anti-C5 antibody combinations and uses thereof
granted -
US 11357795
Combination immunotherapies for treatment of cancer
granted -
US 11351153
Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent
granted -
US 11338013
Combination therapy for C3 inhibition
granted -
US 11331370
Combination product for the prevention of sexually transmitted infections
granted -
US 11324822
Combination of HDAC inhibitor and anti-PD-1 antibody for treatment of cancer
granted